About this Research Topic
Genome editing in cancer and immunology represents a rapidly evolving field that has seen remarkable advancements in recent years. The advent of technologies such as CRISPR-Cas9 has revolutionized our ability to manipulate genetic material with unprecedented precision, offering new avenues for therapeutic interventions. Despite these advancements, significant challenges remain, including the need to improve the specificity and efficiency of genome editing tools, address ethical concerns, and understand the long-term effects of genetic modifications. Recent studies have demonstrated promising results in using genome editing to target cancer cells and modulate immune responses, yet the translation of these findings into clinical applications is still in its infancy. The field is currently grappling with questions about the best strategies to ensure safety and efficacy, as well as the potential for off-target effects. Addressing these issues is crucial for the continued development and application of genome editing technologies in cancer and immunology.
This research topic aims to explore the progress made in genome editing over the past decade, focusing on its applications in cancer and immunology. The objective is to provide a comprehensive overview of the current state of the field, identify the greatest challenges, and propose strategies to overcome these obstacles. By highlighting recent developments and major accomplishments, this collection seeks to inspire and guide future research efforts. Key questions include how to enhance the precision of genome editing tools, the ethical implications of genetic modifications, and the potential for clinical translation.
To gather further insights in the field of genome editing in cancer and immunology, we welcome articles addressing, but not limited to, the following themes:
- Advances in CRISPR-Cas9 and other genome editing technologies
- Strategies for improving specificity and efficiency of genome editing
- Ethical considerations in genome editing applications
- Long-term effects and safety of genetic modifications
- Clinical translation of genome editing in cancer therapy
- Modulation of immune responses through genome editing
- Overcoming challenges in targeting cancer cells with genome editing
- Future perspectives and potential breakthroughs in the field
This research topic aims to explore the progress made in genome editing over the past decade, focusing on its applications in cancer and immunology. The objective is to provide a comprehensive overview of the current state of the field, identify the greatest challenges, and propose strategies to overcome these obstacles. By highlighting recent developments and major accomplishments, this collection seeks to inspire and guide future research efforts. Key questions include how to enhance the precision of genome editing tools, the ethical implications of genetic modifications, and the potential for clinical translation.
To gather further insights in the field of genome editing in cancer and immunology, we welcome articles addressing, but not limited to, the following themes:
- Advances in CRISPR-Cas9 and other genome editing technologies
- Strategies for improving specificity and efficiency of genome editing
- Ethical considerations in genome editing applications
- Long-term effects and safety of genetic modifications
- Clinical translation of genome editing in cancer therapy
- Modulation of immune responses through genome editing
- Overcoming challenges in targeting cancer cells with genome editing
- Future perspectives and potential breakthroughs in the field
Keywords: genome editing, cancer, immunology
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
